A gerovital h3 injection course at DRV Clinic is described as 12 injections, commonly scheduled three times per week over approximately four weeks. Before treatment begins, the exact product, medical suitability, allergies, medicines, prescribing arrangements, expected benefits, limitations and possible adverse reactions should be reviewed. The course should not be presented as a guaranteed way to reverse ageing or treat an unexplained medical symptom.

Booking a course is different from booking one isolated injection.

There is a schedule to understand, appointments to attend, reactions to monitor and a decision to make about whether the complete course is appropriate in the first place.

Patients often arrive after reading about Professor Ana Aslan, Romanian longevity medicine or personal Gerovital reviews. Others are looking for help with low energy, reduced resilience, mood or the feeling that they are ageing more quickly than they would like.

Those concerns deserve a proper conversation.

At DRV Clinic in Marylebone, a gerovital h3 injections consultation should establish what the patient hopes to achieve, whether another medical assessment is needed and whether the proposed product and course are appropriate.

The Gerovital Course at a Glance

Part of the course

What to expect

Initial consultation

Review of goals, medical history, allergies, medicines, previous reactions and the exact product proposed

Published DRV schedule

12 injections, described as three appointments per week

Approximate course length

Around four weeks where the full schedule is followed

Appointment length

Confirm directly with the clinic; the injection itself may be brief, but assessment and observation may add time

Result timeline

Subjective changes, if any, may not follow a predictable schedule

Downtime

Many patients may continue normal activity, but local reactions or systemic symptoms can occur

Follow-up

Concerns or adverse reactions should be reported rather than waiting for the next routine appointment

Evidence

Broad anti-ageing claims are not supported by strong contemporary clinical evidence

What Is a Gerovital H3 Injection Course?

A gerovital h3 injection course is a planned series of injections rather than a one-off appointment.

The DRV Clinic service page currently describes:

  • 12 injections
  • Three gerovital injections per week
  • A course lasting roughly four weeks

This schedule resembles regimens used in some historical Gerovital research, although old study protocols varied in dose, duration and formulation. A schedule used in a past study does not prove that the course produces anti-ageing benefits.

The exact plan should be confirmed before payment because clinic schedules, products and prices can change.

Why Is a Consultation Needed First?

Gerovital is associated with procaine, a medicine capable of producing pharmacological effects and adverse reactions. It should not be approached like a beauty supplement or ordinary vitamin injection.

Before the first appointment, the consultation should review:

  • The reason treatment is being considered
  • Symptoms such as fatigue, low mood or cognitive change
  • Medical conditions
  • Previous allergic reactions
  • Reactions to local anaesthetics
  • Current prescriptions and over-the-counter medicines
  • Supplements and injectable treatments
  • Pregnancy or breastfeeding
  • Bleeding risk
  • Infection or current illness
  • Previous experience with Gerovital
  • The exact manufacturer and product
  • Product licensing and sourcing
  • The intended route of administration
  • The proposed number of appointments
  • The plan if an adverse reaction occurs

A course should not delay medical assessment where fatigue, weakness, memory problems, depression or reduced stamina could reflect anaemia, thyroid disease, infection, sleep problems, nutritional deficiency, medication effects or another condition.

What Product Will Be Used?

The phrase gerovital injection does not provide enough information on its own.

Before proceeding, ask to see:

  • Product name
  • Manufacturer
  • Original packaging
  • Ingredient list
  • Batch number
  • Expiry date
  • Patient information supplied with the product
  • Storage requirements
  • Importer or supplier information where relevant

DRV Clinic has confirmed that its service refers to Gerovital H3 injectable ampoules. The exact brand, formulation and regulatory status still need to be explained to each patient.

A product should not be described as UK-licensed unless that claim has been verified for the exact ampoule and intended use.

The MHRA explains that an unlicensed medicine has no UK marketing authorisation and may not have been assessed by the agency. Its supply is permitted only under defined conditions for an individual patient’s clinical need and under an authorised prescriber’s responsibility. Read the MHRA guidance on unlicensed medicines.

How Should I Prepare for the First Appointment?

Follow the instructions supplied by the clinic, because individual advice may differ.

General preparation may include:

  • Provide an accurate medicine and allergy list.
  • Report any illness, infection, fever or new symptoms.
  • Tell the clinic if you are pregnant, trying to conceive or breastfeeding.
  • Avoid arriving dehydrated or after prolonged fasting unless specifically instructed.
  • Wear clothing that allows comfortable access to the planned injection area.
  • Do not apply heavy products over the injection site.
  • Avoid alcohol or recreational substances before treatment.
  • Do not stop prescribed anticoagulants or other medicines without the prescriber’s advice.
  • Arrange sufficient time so the appointment is not rushed.

If you have had an allergic reaction to an injectable medicine or local anaesthetic, provide as much detail as possible about the product, timing and symptoms.

What Happens at Each Appointment?

The process may differ according to the product, route and practitioner, but a typical appointment may involve:

  1. Health update

The practitioner asks whether anything has changed since the previous injection, including medicines, illness or reactions.

  1. Confirmation of the product

The ampoule, batch and expiry should be checked according to clinic procedure.

  1. Injection-site preparation

The planned area is cleaned and prepared.

  1. Administration

The gerovital injection is administered using the prescribed route and dose.

  1. Immediate observation

The patient may be monitored for an appropriate period, especially after the first injection or where there is an allergy history.

  1. Aftercare reminder

The patient is told what reactions may be expected, what to avoid and how to contact the clinic.

  1. Documentation

The treatment, product details and any reaction should be recorded.

The next injection should not proceed automatically if a patient developed a concerning reaction after the previous appointment.

What Does the Four-Week Schedule Look Like?

Where the DRV Clinic schedule of three appointments per week is followed, the course may look like this:

Week

Possible schedule

Main purpose of review

Week 1

Injections 1-3

Confirm early tolerance and identify immediate reactions

Week 2

Injections 4-6

Review any changes in symptoms, bruising or systemic effects

Week 3

Injections 7-9

Decide whether continuing remains appropriate

Week 4

Injections 10-12

Complete the planned course and arrange final review

This is an example based on the published three-per-week structure. Appointment days and intervals must be confirmed by the clinic.

Missing one appointment does not mean a patient should double the next dose or compress the schedule without clinical advice.

What Should I Expect After an Injection?

Many people may feel able to continue normal activities, but a reaction-free experience cannot be guaranteed.

Possible short-term effects include:

  • Local stinging or soreness
  • Tenderness
  • Redness
  • Mild swelling
  • Bruising
  • Dizziness or light-headedness
  • Headache
  • Nausea
  • Feeling tired or unsettled

These symptoms should be monitored. A reaction that becomes stronger, lasts longer than expected or recurs after each injection should be discussed before the next appointment.

Gerovital Aftercare

The exact gerovital aftercare instructions depend on the injection site, product and patient.

General advice may include:

  • Keep the injection site clean.
  • Avoid rubbing or massaging the area unless advised.
  • Avoid strenuous exercise immediately after treatment if the practitioner recommends it.
  • Avoid excessive heat, sauna or hot bathing during the early period if the area is irritated.
  • Do not apply unapproved products to the injection site.
  • Maintain normal hydration.
  • Record any symptoms and when they began.
  • Keep the clinic’s contact information available.
  • Follow instructions regarding the next appointment.

The absence of visible redness does not prove that a systemic reaction cannot occur. Pay attention to how you feel as well as how the injection site looks.

What Reactions Are Not Normal?

Seek urgent medical help for:

  • Difficulty breathing
  • Swelling of the tongue, lips, face or throat
  • Widespread hives
  • Collapse or fainting
  • Severe chest pain
  • A significant or sustained abnormal heartbeat sensation
  • Sudden confusion, weakness or neurological symptoms

Contact the clinic promptly for:

  • Increasing pain at the injection site
  • Spreading redness or heat
  • Pus or discharge
  • Fever
  • Persistent vomiting
  • Recurrent dizziness
  • A significant rash
  • Symptoms that worsen after each injection

These warning signs should not be ignored simply because another appointment is already booked.

Gerovital Injection Side Effects During a Course

Possible gerovital injection side effects can occur after the first injection or later in the course.

Repeated exposure may matter because:

  • An allergic reaction can occur even when an earlier dose was tolerated.
  • Bruising may accumulate across repeated injection sites.
  • A pattern of headaches, dizziness or nausea may become clearer.
  • New medicines or illness may alter suitability during the course.
  • Patients may feel pressure to finish a prepaid course despite concerns.

Clinical review should continue throughout the programme. Consent is an ongoing process, not a signature obtained only at the first appointment.

What If I Miss an Injection?

Contact the clinic rather than changing the schedule yourself.

Do not:

  • Take two injections together
  • Attend on consecutive days unless specifically instructed
  • Extend the course without review
  • Use an ampoule independently
  • Ask another provider to administer a dose without complete product and prescribing information

The safest revised schedule depends on the interval, reason for the missed appointment and the patient’s response so far.

When Should the Course Be Paused or Stopped?

The course may need reassessment if:

  • An allergic or systemic reaction occurs
  • Injection sites show signs of infection
  • A new medical condition is diagnosed
  • A new medicine is started
  • Pregnancy occurs
  • The patient becomes acutely unwell
  • The proposed product changes
  • The patient no longer wishes to continue
  • The expected benefit no longer justifies the burden or risk

Finishing all 12 injections is not more important than patient safety.

When Might I Notice a Benefit?

There is no validated timeline showing that all patients experience a specific Gerovital benefit after a certain number of injections.

A patient may report changes in:

  • Energy
  • Mood
  • Sleep
  • General wellbeing
  • Physical comfort
  • Skin appearance

However, these outcomes are subjective and can be influenced by expectation, lifestyle, placebo response, concurrent treatment and natural variation.

The evidence does not support promising that a particular benefit will appear after injection three, six or twelve.

A final review should ask whether any change was meaningful, whether it was measured consistently and whether adverse effects occurred.

What Does the Evidence Say About a Course?

Historical Gerovital studies used repeated injection schedules, but controlled research has not demonstrated reliable broad anti-ageing benefit.

A double-blind study involving geriatric psychiatric patients used injections three times per week and found no systematic physiological or psychological advantage over placebo. Read the Gerovital H3 controlled study.

A review of systemic procaine literature concluded that there was no convincing evidence for treating ageing or common diseases in older people. Read the systemic procaine review.

The Cochrane review of procaine for cognition found stronger evidence for side effects than cognitive benefit.

This evidence does not prove that no patient can report a subjective improvement. It means a clinic should avoid guaranteed claims and explain uncertainty before a full course is purchased.

How Much Does a Gerovital H3 Course Cost?

DRV Clinic’s Gerovital service page has displayed conflicting prices for a 12-injection course.

Before booking, request one written quotation that states:

  • Total price
  • Number of injections
  • Whether consultation is included
  • Whether prescribing is included
  • Whether all ampoules and consumables are included
  • Whether review appointments are included
  • Cancellation and missed-appointment terms
  • What happens if treatment is stopped for medical reasons

The final price should be confirmed directly with DRV Clinic before payment.

Gerovital H3 Injection Course at DRV Clinic in London

DRV Clinic is located at:

1st Floor, 136 Baker Street

Marylebone

London

W1U 6UD

The clinic is close to Baker Street Underground station and accessible from Marylebone, Mayfair, Fitzrovia, St John’s Wood and other parts of Central London.

Patients can review the Gerovital injections service page and read the clinic’s article on Gerovital H3’s Romanian history before arranging a consultation.

Frequently Asked Questions

The current service page describes a course of 12 gerovital h3 injections.

DRV Clinic describes three injections per week, which would usually make the course approximately four weeks long.

Yes. Medical history, allergies, medicines, the exact product, regulatory status and realistic expectations should be reviewed before treatment.

Availability and clinical appropriateness should be discussed with the clinic. One injection does not establish whether a full course will provide benefit.

Contact the clinic. Do not double a dose or compress the remaining schedule without clinical advice.

The clinic may advise temporarily avoiding strenuous activity, particularly where there is soreness, dizziness or another reaction. Follow the personalised instructions supplied.

There is no reliable evidence-based timetable. Some patients report subjective changes, while others notice no benefit.

Possible effects include injection-site pain, bruising, redness, dizziness, headache, nausea, allergic reaction and infection.

No. A course should not be sold with a guarantee of improved energy, cognition, skin or biological age.

Yes. Consent can be withdrawn, and treatment should be reviewed or stopped if safety concerns, illness, new medicines or significant adverse reactions occur.

A Course Should Remain a Clinical Decision

The convenience of a 12-appointment package can make Gerovital feel like a predictable programme.

The biology is less predictable.

Each injection creates another opportunity to review tolerance, changes in health and whether continuing remains justified. The course should never become an obligation simply because it has been booked or paid for.

At DRV Clinic in Marylebone, a responsible gerovital h3 injection course should be transparent about product details, schedule, evidence, side effects, price and follow-up.

The purpose of planning is not merely to complete 12 injections.

It is to make sure every appointment still makes sense for the person receiving it.

This article provides general information only and does not replace individual medical advice, diagnosis, prescribing or informed consent.

Sources and Further Reading